These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21084035)

  • 1. Atorvastatin-induced acute elevation of hepatic enzymes and the absence of cross-toxicity of pravastatin.
    Liu Y; Cheng Z; Ding L; Fang F; Cheng KA; Fang Q; Shi GP
    Int J Clin Pharmacol Ther; 2010 Dec; 48(12):798-802. PubMed ID: 21084035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin: a safety and tolerability profile.
    Arca M
    Drugs; 2007; 67 Suppl 1():63-9. PubMed ID: 17910522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial.
    Saw J; Steinhubl SR; Berger PB; Kereiakes DJ; Serebruany VL; Brennan D; Topol EJ;
    Circulation; 2003 Aug; 108(8):921-4. PubMed ID: 12925453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
    Nissen SE; Tuzcu EM; Schoenhagen P; Brown BG; Ganz P; Vogel RA; Crowe T; Howard G; Cooper CJ; Brodie B; Grines CL; DeMaria AN;
    JAMA; 2004 Mar; 291(9):1071-80. PubMed ID: 14996776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial.
    Saw J; Brennan DM; Steinhubl SR; Bhatt DL; Mak KH; Fox K; Topol EJ;
    J Am Coll Cardiol; 2007 Jul; 50(4):291-5. PubMed ID: 17659194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of cholesteryl ester transfer protein mass with peripheral leukocyte count following statin therapy: a pilot study.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2012 Oct; 12(5):349-54. PubMed ID: 22900989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune hepatitis revealed by atorvastatin.
    Pelli N; Setti M; Ceppa P; Toncini C; Indiveri F
    Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):921-4. PubMed ID: 12867804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk management of simvastatin or atorvastatin interactions with CYP3A4 inhibitors.
    Molden E; Skovlund E; Braathen P
    Drug Saf; 2008; 31(7):587-96. PubMed ID: 18558792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia.
    Gentile S; Turco S; Guarino G; Sasso CF; Amodio M; Magliano P; Salvatore T; Corigliano G; Agrusta M; De Simone G; Gaeta I; Oliviero B; Torella R
    Diabetes Obes Metab; 2000 Dec; 2(6):355-62. PubMed ID: 11225965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hepatic injury with atorvastatin: an unusual occurrence.
    Vishwakarma P; Nehra R; Kumar A
    Indian J Pharmacol; 2014; 46(3):343-4. PubMed ID: 24987187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral neuropathy and lipid-lowering therapy.
    Ziajka PE; Wehmeier T
    South Med J; 1998 Jul; 91(7):667-8. PubMed ID: 9671841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).
    Jones PH; Davidson MH; Stein EA; Bays HE; McKenney JM; Miller E; Cain VA; Blasetto JW;
    Am J Cardiol; 2003 Jul; 92(2):152-60. PubMed ID: 12860216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute onset and worsening of diabetes concurrent with administration of statins.
    Ohmura C; Watada H; Hirose T; Tanaka Y; Kawamori R
    Endocr J; 2005 Jun; 52(3):369-72. PubMed ID: 16006732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated platelet inhibition by switching from atorvastatin to a non-CYP3A4-metabolized statin in patients with high platelet reactivity (ACCEL-STATIN) study.
    Park Y; Jeong YH; Tantry US; Ahn JH; Kwon TJ; Park JR; Hwang SJ; Gho EH; Bliden KP; Kwak CH; Hwang JY; Kim S; Gurbel PA
    Eur Heart J; 2012 Sep; 33(17):2151-62. PubMed ID: 22507978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness.
    Taylor AJ; Kent SM; Flaherty PJ; Coyle LC; Markwood TT; Vernalis MN
    Circulation; 2002 Oct; 106(16):2055-60. PubMed ID: 12379573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin-associated exacerbation of myasthenia gravis.
    Cartwright MS; Jeffery DR; Nuss GR; Donofrio PD
    Neurology; 2004 Dec; 63(11):2188. PubMed ID: 15596782
    [No Abstract]   [Full Text] [Related]  

  • 17. Paradoxical decrease in HDL-cholesterol and apolipoprotein A1 with simvastatin and atorvastatin in a patient with type 2 diabetes.
    Ramachandran S; Saraf S; Shetty C; Capps N; Bailey C
    Ann Clin Biochem; 2011 Jan; 48(Pt 1):75-8. PubMed ID: 21115572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute cholestatic hepatitis after atorvastatin reintroduction].
    de Castro ML; Hermo JA; Baz A; de Luaces C; Pérez R; Clofent J
    Gastroenterol Hepatol; 2006 Jan; 29(1):21-4. PubMed ID: 16393626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. More Western hypercholesterolemic patients achieve Japan Atherosclerosis Society LDL-C goals with rosuvastatin therapy than with atorvastatin, pravastatin, or simvastatin therapy.
    Strutt K; Caplan R; Hutchison H; Dane A; Blasetto J
    Circ J; 2004 Feb; 68(2):107-13. PubMed ID: 14745143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse events with concomitant amiodarone and statin therapy.
    Alsheikh-Ali AA; Karas RH
    Prev Cardiol; 2005; 8(2):95-7. PubMed ID: 15860984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.